Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease. Studies in Drosophila showed that genetic increase of the levels of the bioactive sphingolipid sphingosine-1-phosphate (S1P) or delivery of 2-acetyl-5-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, suppresses dystrophi...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2014-01-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/7/1/41 |
id |
doaj-8882fdb5b28248409e6f922a2a11cbc5 |
---|---|
record_format |
Article |
spelling |
doaj-8882fdb5b28248409e6f922a2a11cbc52020-11-25T02:00:14ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112014-01-0171415410.1242/dmm.013631013631Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophyDiem-Hang Nguyen-TranNitai C. HaitHenrik SperberJunlin QiKarin FischerNick IeronimakisMario PantojaAislinn HaysJeremy AllegoodMorayma ReyesSarah SpiegelHannele Ruohola-BakerDuchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease. Studies in Drosophila showed that genetic increase of the levels of the bioactive sphingolipid sphingosine-1-phosphate (S1P) or delivery of 2-acetyl-5-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, suppresses dystrophic muscle degeneration. In the dystrophic mouse (mdx), upregulation of S1P by THI increases regeneration and muscle force. S1P can act as a ligand for S1P receptors and as a histone deacetylase (HDAC) inhibitor. Because Drosophila has no identified S1P receptors and DMD correlates with increased HDAC2 levels, we tested whether S1P action in muscle involves HDAC inhibition. Here we show that beneficial effects of THI treatment in mdx mice correlate with significantly increased nuclear S1P, decreased HDAC activity and increased acetylation of specific histone residues. Importantly, the HDAC2 target microRNA genes miR-29 and miR-1 are significantly upregulated, correlating with the downregulation of the miR-29 target Col1a1 in the diaphragm of THI-treated mdx mice. Further gene expression analysis revealed a significant THI-dependent decrease in inflammatory genes and increase in metabolic genes. Accordingly, S1P levels and functional mitochondrial activity are increased after THI treatment of differentiating C2C12 cells. S1P increases the capacity of the muscle cell to use fatty acids as an energy source, suggesting that THI treatment could be beneficial for the maintenance of energy metabolism in mdx muscles.http://dmm.biologists.org/content/7/1/41HDACS1PTHIdysDystrophinmdx |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Diem-Hang Nguyen-Tran Nitai C. Hait Henrik Sperber Junlin Qi Karin Fischer Nick Ieronimakis Mario Pantoja Aislinn Hays Jeremy Allegood Morayma Reyes Sarah Spiegel Hannele Ruohola-Baker |
spellingShingle |
Diem-Hang Nguyen-Tran Nitai C. Hait Henrik Sperber Junlin Qi Karin Fischer Nick Ieronimakis Mario Pantoja Aislinn Hays Jeremy Allegood Morayma Reyes Sarah Spiegel Hannele Ruohola-Baker Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy Disease Models & Mechanisms HDAC S1P THI dys Dystrophin mdx |
author_facet |
Diem-Hang Nguyen-Tran Nitai C. Hait Henrik Sperber Junlin Qi Karin Fischer Nick Ieronimakis Mario Pantoja Aislinn Hays Jeremy Allegood Morayma Reyes Sarah Spiegel Hannele Ruohola-Baker |
author_sort |
Diem-Hang Nguyen-Tran |
title |
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy |
title_short |
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy |
title_full |
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy |
title_fullStr |
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy |
title_full_unstemmed |
Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy |
title_sort |
molecular mechanism of sphingosine-1-phosphate action in duchenne muscular dystrophy |
publisher |
The Company of Biologists |
series |
Disease Models & Mechanisms |
issn |
1754-8403 1754-8411 |
publishDate |
2014-01-01 |
description |
Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease. Studies in Drosophila showed that genetic increase of the levels of the bioactive sphingolipid sphingosine-1-phosphate (S1P) or delivery of 2-acetyl-5-tetrahydroxybutyl imidazole (THI), an S1P lyase inhibitor, suppresses dystrophic muscle degeneration. In the dystrophic mouse (mdx), upregulation of S1P by THI increases regeneration and muscle force. S1P can act as a ligand for S1P receptors and as a histone deacetylase (HDAC) inhibitor. Because Drosophila has no identified S1P receptors and DMD correlates with increased HDAC2 levels, we tested whether S1P action in muscle involves HDAC inhibition. Here we show that beneficial effects of THI treatment in mdx mice correlate with significantly increased nuclear S1P, decreased HDAC activity and increased acetylation of specific histone residues. Importantly, the HDAC2 target microRNA genes miR-29 and miR-1 are significantly upregulated, correlating with the downregulation of the miR-29 target Col1a1 in the diaphragm of THI-treated mdx mice. Further gene expression analysis revealed a significant THI-dependent decrease in inflammatory genes and increase in metabolic genes. Accordingly, S1P levels and functional mitochondrial activity are increased after THI treatment of differentiating C2C12 cells. S1P increases the capacity of the muscle cell to use fatty acids as an energy source, suggesting that THI treatment could be beneficial for the maintenance of energy metabolism in mdx muscles. |
topic |
HDAC S1P THI dys Dystrophin mdx |
url |
http://dmm.biologists.org/content/7/1/41 |
work_keys_str_mv |
AT diemhangnguyentran molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT nitaichait molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT henriksperber molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT junlinqi molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT karinfischer molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT nickieronimakis molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT mariopantoja molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT aislinnhays molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT jeremyallegood molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT moraymareyes molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT sarahspiegel molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy AT hanneleruoholabaker molecularmechanismofsphingosine1phosphateactioninduchennemusculardystrophy |
_version_ |
1724961876266188800 |